Obesity experts spotlight safety gap in clinical trials and drug labeling for people with obesity

A new opinion piece published in Health Affairs Forefront raises questions around current approaches to assess drug safety and effectiveness in people with obesity. The article sheds light on how increased body fat can modify the effects of drugs used to treat common conditions, in some cases rendering the drugs ineffective or unsafe for people with obesity.